(Q39631113)

13 September 2017

title

Nanotoxicity: how the body develops a way to reduce the toxicity of carbon nanotubes (English)

1 reference

13 September 2017

1 reference

Kristina Riehemann

1

1 reference

13 September 2017

language of work or name

1 reference

4 April 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

8

1 reference

13 September 2017

issue

13

1 reference

13 September 2017

page(s)

1970-1972

1 reference

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200400

Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200400

Toxicology of nanomaterials used in nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200400

Material properties in complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200400

Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200400

Nanotoxicology: an interdisciplinary challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200400

Binding of blood proteins to carbon nanotubes reduces cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201200400

21 January 2018

Identifiers

DOI

10.1002/SMLL.201200400

1 reference

13 September 2017

1 reference